FDA conducts inspection of These Three Medical, LLC in Miami on Jan. 8, 2024

Mark Raza Principal Deputy Chief Counsel - FDA
Mark Raza Principal Deputy Chief Counsel - FDA - Official Website
0Comments

The Food and Drug Administration (FDA) carried out an inspection of These Three Medical, LLC located in Miami on January 8, 2024, according to data posted on the FDA’s website.

The inspection covered the following areas:

  • Compliance: Devices
  • Postmarket Assurance: Devices

The FDA’s final report concluded that These Three Medical, LLC was not required to implement any corrective actions regarding its operational management.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Rodney S. Scott, Commissioner of U.S. Customs and Border Protection

CBP and CBSA announce joint NEXUS enrollment event in South Florida

U.S. Customs and Border Protection (CBP), together with the Canada Border Services Agency (CBSA), will hold a NEXUS enrollment event for conditionally approved applicants in Miami and Fort Lauderdale.

Joseph B. Edlow, Director, U.S. Citizenship and Immigration Services (left) and Angelica Alfonso-Royals, Deputy Director, U.S. Citizenship and Immigration Services -

H-1B approvals for employers classified under Public Administration industry across Miami Courant publication area in 2024

In 2024, 100% of H-1B petitions filed by Public Administration employers across Miami Courant publication area were approved, according to data from the U.S. Citizenship and Immigration Services via the H-1B Employer Data Hub.

Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda)

Diego A. Rielo, M.D. undergoes FDA inspection in Miami on June 21, 2024

On June 21, 2024, the Food and Drug Administration (FDA) conducted a bioresearch monitoring inspection of Diego A. Rielo, M.D. in Miami, resulting in two citations, according to information available on the FDA’s official website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Miami Courant.